|
|
|
Volumn 36, Issue 12, 1998, Pages 636-641
|
|
Bioavailabitity of repaglinide, a novel antidiabetic agent, administered orally in tablet or solution form or intravenously in healthy male volunteers
a,d
|
|
Author keywords
Bioavailability; Pharmacokinetics; Prandial glucose regulation; Repaglinide; Subject variability
|
|
Indexed keywords
ANTIDIABETIC AGENT;
REPAGLINIDE;
CARBAMIC ACID DERIVATIVE;
PIPERIDINE DERIVATIVE;
ADULT;
AREA UNDER THE CURVE;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CROSSOVER PROCEDURE;
DRUG ABSORPTION;
DRUG BIOAVAILABILITY;
DRUG ELIMINATION;
HUMAN;
HUMAN EXPERIMENT;
INTRAVENOUS DRUG ADMINISTRATION;
MALE;
MEAN RESIDENCE TIME;
ORAL DRUG ADMINISTRATION;
RANDOMIZED CONTROLLED TRIAL;
TABLET;
ADOLESCENT;
BIOAVAILABILITY;
CONTROLLED STUDY;
INSULIN DEPENDENT DIABETES MELLITUS;
MIDDLE AGED;
ADMINISTRATION, ORAL;
ADOLESCENT;
ADULT;
AREA UNDER CURVE;
BIOLOGICAL AVAILABILITY;
CARBAMATES;
CROSS-OVER STUDIES;
DIABETES MELLITUS, TYPE 1;
HUMANS;
HYPOGLYCEMIC AGENTS;
INFUSIONS, INTRAVENOUS;
MALE;
MIDDLE AGED;
PIPERIDINES;
TABLETS;
|
|
EID: 0031593457
PISSN: 09461965
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (74)
|
|
References (6)
|
